Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-03 · accession 0001209191-23-007381 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-06 | 2023-02-03 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale | $11.01 | -61.0K | 219.2K | -22% | -$672.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-03 | S | D | 61,040 | $11.01 | 219,184 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $10.61 to $11.26 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |